Pulse Biosciences (PLSE) Total Debt (2021 - 2023)
Pulse Biosciences' quarterly Total Debt came in at $65.0 million in Q1 2023, little changed quarter-over-quarter from $65.0 million in Q4 2022.
Pulse Biosciences has reported Total Debt for 3 years, with the latest figure at $65.0 million in Q1 2023.
- For the quarter ending Q1 2023, Total Debt changed N/A year-over-year to $65.0 million; the trailing twelve-month figure through Mar 2023 stood at $65.0 million (changed N/A YoY), and the FY2022 full-year result was $65.0 million, changed N/A from the prior year.
- Total Debt for Q1 2023 stood at $65.0 million, roughly flat from $65.0 million in the prior quarter.
- The five-year high for Total Debt was $65.0 million in Q3 2022, with the low at $41.0 million in Q1 2021.
- Average Total Debt over 3 years is $59.0 million, with a median of $65.0 million recorded in 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 17.28 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 259.93 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 202.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 5.08 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 2.50 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 9.46 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 1.18 Bn |
| 10 | Pulse Biosciences | 1.72 Bn | 1.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 65.00 Mn |
| Dec 31, 2022 | 65.00 Mn |
| Sep 30, 2022 | 65.00 Mn |
| Mar 31, 2021 | 41.00 Mn |